Article
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma.
Blood - 24 Feb 2011
Rossi Davide, Rasi Silvia, Di Rocco Alice, Fabbri Alberto, Forconi Francesco, Gloghini Annunziata, Bruscaggin Alessio, Franceschetti Silvia, Fangazio Marco, De Paoli Lorenzo, Bruna Riccardo, Capello Daniela, Chiappella Annalisa, Lobetti Bodoni Chiara, Giachelia Manuela, Tisi Maria Chiara, Pogliani Enrico M, Lauria Francesco, Ladetto Marco, Hohaus Stefan, Martelli Maurizio, Vitolo Umberto, Carbone Antonino, Foà Robin, Gaidano Gianluca
Abstract excerpt
Several drugs used for diffuse large B-cell lymphoma (DLBCL) treatment rely on DNA damage for tumor cell killing. We verified the prognostic impact of the host DNA repair genotype in 2 independent cohorts of DLBCL treated with R-CHOP21 (training cohort, 163 cases; validation cohort, 145 cases). A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
